An expert discusses how the lack of transparency in medication pricing creates a "black box" between actual drug costs and patient expenses, negatively affecting both patient care and the health care ...

NICE has recommended delgocitinib cream for adults with moderate-to-severe chronic hand eczema unresponsive to ...

Codex Labs has announced the launch of the first product in a new collection, KĀNGFÙ, that is focused on healing damaged skin ...

A significant advance in treatment of patients with immunity to AAVs previously ineligible for clinical trials and existing ...

United States: Projected CAGR of 5.1%, with market value rising from USD 127.3 billion in 2025 to USD 209.4 billion by 2035, ...

STRATA Skin Sciences, Inc. (NASDAQ: SSKN) is marking Eczema Awareness Month by underscoring the growing body of clinical evidence supporting its XTRAC® Excimer Laser (308 nm) as ...

Meditation, biofeedback, aromatherapy, and other such therapies can relieve stress caused by psoriasis and fend off stress-triggered flares.

“The excimer laser is one of our most effective treatments for localized eczema,” said Dr. Mark G. Lebwohl, M.D., Dean for Clinical Therapeutics, Professor and Chairman Emeritus, Department of ...

The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of plaque psoriasis and active ...

TREMFYA® is now approved for pediatric patients living with moderate to severe plaque psoriasis, who are candidates for systemic therapy or phototherapy, and active psoriatic arthritis in children six ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...